1. Home
  2.  » 
  3. Catalent News
  4.  » Catalent Receives Certificate of Recognition from Tangzhen Government

Catalent Receives Certificate of Recognition from Tangzhen Government

SOMERSET, N.J. – December 16, 2019 — Catalent, a global leader in clinical supply services, was recently awarded a certificate of recognition from the Shanghai Tangzhen government to acknowledge the company’s successful investment and operations in the region. The certificate was presented by senior government officials at an official ceremony at the Pudong New Area Tangzhen Government Building in Shanghai, close to Catalent’s 30,000 sq. ft Tangzhen clinical supply facility.

Completed earlier this year, Catalent’s Tangzhen site is near to both the company’s existing Waigaoqiao FTZ site and China’s Zhangjiang Pharma Valley area and offers comprehensive clinical supply services including FastChain® demand-led supply, secondary packaging, clinical storage and local distribution, as well as clinical returns and destruction services.

Pictured at the official ceremony (l to r) are: Zhong Shen, Director, Investment Promotion Office, Tangzhen; GuoPing Li, Vice Town Mayor, Tangzhen; Dr. TengLan Chen, Town Mayor & Deputy General Secretary, Tangzhen; WeiGuo Jin, General Secretary, Tangzhen; Paul Hegwood, President, Catalent Clinical Supply Services (CSS); Mike Shearer, Vice President of Global Business Development, Catalent CSS; Daniel Gao, General Manager, Catalent Shanghai; Josee Xu, Asia Pacific Business Development Director, Catalent CSS; Kate Rimmer, Director, Project Management, Catalent CSS; and Simeon Chen, Facility Project Manager, Catalent Shanghai.

To find out more about Catalent’s clinical supply services, visit www.clinical.catalent.com

Notes for Editors

ABOUT CATALENT

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com

 

More products. Better treatments. Reliably supplied.™